At-home testing for prostate cancer using PSA levels
Official title: TOPIC 455: IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING
Funded at Electronic Biosciences, INC. · NIH-11219743 · Data updated 2026-11-12
This study is working on a new, easy-to-use home testing device that helps men check their PSA levels for early signs of prostate cancer, making it simpler and more affordable for everyone to take care of their prostate health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2025 |
| Funding year | 2024 |
| Award (this year) | $389,535 |
| NIH project number | 75N91024C00077-0-9999-1 |
| Project ID | NIH-11219743 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men at risk for prostate cancer, particularly those who may not have regular access to healthcare services.
✕Less likely to help
Patients who have already been diagnosed with advanced prostate cancer may not benefit from this research.
What this research studies
This research focuses on developing a new, affordable at-home testing device for prostate-specific antigen (PSA) levels, which can help in the early detection of prostate cancer. The device aims to provide a simple, plug-and-play solution that allows men to test their PSA levels without needing to visit a laboratory. By improving the accuracy of PSA testing and reducing false positives, this technology seeks to make prostate health care more accessible, especially for underserved populations. The goal is to enable earlier diagnosis of prostate cancer, which can significantly improve treatment options and survival rates.
Why it matters
Potential benefit: If successful, this research could provide a cost-effective and accessible method for early detection of prostate cancer, potentially saving lives.
How similar studies have gone: Previous research has shown promise in developing at-home diagnostic tests for various conditions, indicating that this approach could be successful.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: Ervin, Eric — Electronic Biosciences, INC.
- Study coordinator: Ervin, Eric
Related research
Other NIH-funded projects on the same topics.
-
Enabling protein sequencing with tiny nanopores
A new technology aims to read the exact amino acid sequence of a single protein molecule in real time using tiny protein-based pores.
-
Next-gen single-molecule protein sequencing for cancer profiling
A new single-molecule protein sequencing platform aims to directly read cancer-related proteins with ultra-high accuracy and through- put to reveal variants and modifications.
-
High-Fidelity DNA Sequencing of FMR1 CGG Repeats and Methylation in Fragile X
A new method will be developed to precisely measure CGG repeats and DNA methylation in the FMR1 gene to improve diagnosis and understanding of Fragile X–related autism.
-
Developing a new method for sequencing proteins using enzymes
This study is working on a new way to read proteins one at a time, which could help doctors get better information about diseases and improve tests for patients, especially for those with rare or complicated proteins.
-
Developing advanced RNA sequencing technologies to understand gene expression and modifications.
This study is working on new ways to read RNA directly, which helps us see how genes work and how changes in RNA can affect our cells, making it easier to understand diseases and improve treatments.
-
Developing quick tests for opioid and stimulant use disorders
This study is working on a quick and easy test to help doctors find out if someone has problems with opioid or stimulant use, so they can get the right care faster, especially in places where help is hard to reach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.